Select Medical Holdings (SEM)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data for Select Medical Holdings, the days of sales outstanding (DSO) is not available for the financial periods indicated. The absence of specific DSO figures makes it challenging to assess the efficiency of the company's accounts receivable management and the average number of days it takes for the company to collect payment from its customers.
Since DSO is a critical metric in evaluating the effectiveness of a company's credit and collections policies, the lack of this information limits the ability to comprehensively analyze the company's financial health and cash flow management. In general, a lower DSO is considered favorable as it indicates quicker collections, efficient credit management, and potentially healthier cash flows.
It would be beneficial for further analysis and decision-making to obtain specific DSO figures for Select Medical Holdings in future financial reports to gain more insights into the company's receivables management practices and potential improvements in working capital efficiency.
Peer comparison
Dec 31, 2024